Controversies in Neuro-Oncology (Avastin and Malignant Gliomas)

Editor(s): Thomas C. Chen

Co-Editor(s): Marc Chamberlain

Indexed in: Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.

Recommend this eBook to your Library

Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small ...
[view complete introduction]

US $
79
Order Library eBook 316
Order Printed Copy *95
Order Ebook + Hard Copy

23% off
$174.00

*134

*(Excluding Mailing and Handling)

Secure Checkout
Personal information is secured with SSL technology



Foreword  promotion: free to download

Pp. i

Victor A. Levin



Preface  promotion: free to download

Pp. ii-iiii (2)

Thomas Chen



Contributors  promotion: free to download

Pp. iv-vii (4)

Thomas C. Chen and Marc Chamberlain



The Basic Science of Avastin (Bevacizumab) Therapy

Pp. 1-6 (6)

Florence M. Hofman and Thomas C. Chen


PDF Price: $30



Avastin for Recurrent Malignant Gliomas

Pp. 7-11 (5)

Annick Desjardins and James J. Vredenburgh


PDF Price: $30



Avastin and Malignant Gliomas: Is there a Role?

Pp. 12-18 (7)

Teri N. Kreisl


PDF Price: $30



An Update on the Role of Anti-Angiogenic Therapy for Newly Diagnosed Glioblastoma

Pp. 28-32 (5)

David A. Reardon, Sith Sathornsumetee and James V. Vredenburgh


PDF Price: $30



Bevacizumab Plus Radiotherapy in Malignant Gliomas: Is there a Role?

Pp. 33-39 (7)

Minesh Mehta, Disha Patel and Arnab Chakravarti


PDF Price: $30



Bevacizumab and Malignant Glioma: Is there a Role for Upfront Therapy?

Pp. 40-45 (6)

Jing Wu and Mark R. Gilbert


PDF Price: $30



Bevacizumab Toxicity in Glioblastoma

Pp. 46-50 (5)

Dawit Aregawi and David Schiff


PDF Price: $30



Bevacizumab in the Treatment of Glioblastoma: Is there an Optimal Dose or Schedule?

Pp. 54-58 (5)

L. Kamsheh, P. Kumthekar and J. J. Raizer


PDF Price: $30



The Radiographic Interpretation of Response to Avastin in Glioblastoma Multiforme

Pp. 74-80 (7)

Nicholas Butowski and Susan Chang


PDF Price: $30



Imaging Responses of Bevacizumab

Pp. 81-93 (13)

R. Thind, Y. S. Mohan and T. Mikkelsen


PDF Price: $30



Assessing Radiographic Response to Bevacizumab in Patients with GBM

Pp. 94-99 (6)

John W. Henson and Bart Keogh


PDF Price: $30



Neurosurgical Implications of Bevacizumab Therapy of Malignant Gliomas

Pp. 100-106 (7)

Manish K. Aghi and Mitchel S. Berger


PDF Price: $30



Neurosurgical Implications of Avastin

Pp. 107-110 (4)

Gazanfar Rahmathulla and Michael A. Vogelbaum


PDF Price: $30



Role of Avastin for Treatment of Central Nervous System Radiation Necrosis

Pp. 117-126 (10)

Jing Wu and Victor A. Levin


PDF Price: $30



Bevacizumab for Recurrent Glioma - A Personal View

Pp. 133-139 (7)

Roger Stupp


PDF Price: $30



The European Perspective Regarding Avastin and Malignant Gliomas

Pp. 147-151 (5)

Wolfgang Wick, Michael Platten and Antje Wick


PDF Price: $30



Development of Sorafenib in Malignant Gliomas: Rationale and Early Clinical Experience

Pp. 162-170 (9)

Rachel Grossman and Jaishri Blakeley


PDF Price: $30



Aflibercept (VEGF-Trap) in High-Grade Gliomas

Pp. 171-175 (5)

Jan Drappatz, Andrew D. Norden and Patrick Y. Wen


PDF Price: $30



Cediranib in Glioblastoma

Pp. 176-183 (8)

Elizabeth R. Gerstner, Jorg H. Dietrich, Daphne Wang and Tracy T. Batchelor


PDF Price: $30



Author Index  promotion: free to download

Pp. 190-191 (2)

Thomas C. Chen and Marc Chamberlain



Index  promotion: free to download

Pp. 192-195 (4)

Bentham Science Publishers